Lipella announces U.S. patent allowance for liposomal drug delivery platform
PremiumThe FlyLipella announces U.S. patent allowance for liposomal drug delivery platform
29d ago
Lipella Pharmaceuticals reports early tolerability results in Phase 2a trial
Premium
The Fly
Lipella Pharmaceuticals reports early tolerability results in Phase 2a trial
2M ago
Lipella Pharmaceuticals launches Oral Lichen Planus patient registry
Premium
The Fly
Lipella Pharmaceuticals launches Oral Lichen Planus patient registry
3M ago
Lipella Pharmaceuticals enrolls first patients in LP-310 trial
PremiumThe FlyLipella Pharmaceuticals enrolls first patients in LP-310 trial
4M ago
Lipella completes site initiation visit for Phase 2a LP-310 trial
Premium
The Fly
Lipella completes site initiation visit for Phase 2a LP-310 trial
6M ago
Lipella announces receipt of FDA Type-C meeting guidance on LP-10
Premium
The Fly
Lipella announces receipt of FDA Type-C meeting guidance on LP-10
6M ago
Lipella Pharmaceuticals announces FDA clearance of IND for LP-410
PremiumThe FlyLipella Pharmaceuticals announces FDA clearance of IND for LP-410
8M ago
Lipella Pharmaceuticals files $50M mixed securities shelf
Premium
The Fly
Lipella Pharmaceuticals files $50M mixed securities shelf
10M ago
Lipella Pharmaceuticals summarizes year with strategic progress, key milestones
Premium
The Fly
Lipella Pharmaceuticals summarizes year with strategic progress, key milestones
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100